Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? [electronic resource]
- Clinical and experimental rheumatology
- 149-53 p. digital
Publication Type: Journal Article
0392-856X
Biomarkers--blood Case-Control Studies Child, Preschool Coronary Aneurysm--blood Enzyme-Linked Immunosorbent Assay Female Fibroblast Growth Factor-23 Fibroblast Growth Factors--blood Humans Infant Logistic Models Male Mucocutaneous Lymph Node Syndrome--blood Multivariate Analysis Odds Ratio Predictive Value of Tests Risk Factors Ultrasonography Up-Regulation